DEMO S.A. announces the inauguration of its new dedicated penem facility

DEMO S.A. today announced the inauguration of its brand new production facility for carbapenems. The new facility has been designed in accordance…

Read More

Meropenem DCP registration proceeds as planned

DEMO Pharmaceutical Industry S.A. today was informed by the UK regulatory authorities that its pan-european registration of its Meropenem injection…

Read More